3M

What 3M does

Solventum, operating the legacy 3M™ Membrana™ medical membrane materials franchise, designs and manufactures specialized capillary membranes from engineered synthetic polymers for integration into medical devices. Its product portfolio spans three primary clinical use cases: blood oxygenation in cardiac surgery and extracorporeal support (OXYPLUS™, OXYPHAN™, X30, HEXPET™), hemodialysis and hemodiafiltration (DIAPES™, PUREMA™, SYNPHAN™), and therapeutic apheresis and plasma fractionation (SYNCLEAR™, MicroPES™ TF10, PLASMAPHAN™, FractioPES™). Each membrane family is engineered with specific pore structures — including asymmetric, sponge-like, and thermally induced phase separation polypropylene architectures — to deliver defined sieving coefficients, biocompatibility, and endotoxin barrier performance tailored to OEM device requirements. Capabilities include customer-specific membrane manufacturing alongside standard product lines.

The business operates a pure OEM/embedded B2B go-to-market, selling membrane materials directly to medical device manufacturers and integrators rather than to end clinical customers. GTM is quote-based via an 'Ask an expert' inquiry form that segments inquiries by OEM/integrator, distributor, end user, or engineering firm, supplemented by an authorized distributor network and a technical resources library of product data sheets and ISO certificates. Pricing is not publicly disclosed. The unit serves global medical device OEMs across more than 35 countries in North America, LATAM, Europe, APAC, the Middle East, and Africa.

Ownership has undergone two consecutive restructurings in an 18-month window. The business originated inside 3M's Health Care segment, was spun off into Solventum in 2024, and the broader Purification and Filtration Business — including these medical membrane materials — was acquired by Thermo Fisher Scientific in 2025. The Wuppertal, Germany facility associated with the Membrana brand employs approximately 120 people.

Name

3M

Legal name

Solventum

Website

https://membrana.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

101–250 employees

Short description

Solventum (formerly 3M Health Care) designs and manufactures 3M™ Membrana™ capillary membranes from engineered polymers for OEM integration into medical devices for blood oxygenation, hemodialysis, and therapeutic apheresis.

Ownership category

akta.pro rank

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales

Revenue model

1. Medical Membrane Materials Sales to OEMs: Sale of specialized capillary membranes to medical device manufacturers (OEMs/integrators) for integration into their medical devices for blood oxygenation, hemodialysis, and therapeutic apheresis applications. The Purification and Filtration Business (including medical membranes) has been acquired by Thermo Fisher Scientific as of 2025.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

3M (Membrana division, now part of Solventum / acquired by Thermo Fisher Scientific in 2025) manufactures and sells specialized capillary membranes under the 3M™ Membrana™ brand for OEM integration into medical devices. The portfolio spans blood oxygenation membranes for cardiac surgery and respiratory therapies, hemodialysis membranes for blood purification, and therapeutic apheresis membranes for plasma separation and fractionation. Products are engineered from synthetic polymers with tailored separation profiles, biocompatibility, and chemical resistance for extracorporeal blood processing devices.

Product overview

Solventum's Medical Membrane Materials portfolio comprises specialized capillary membranes designed for OEM integration into medical devices. The product line spans three primary therapeutic applications: blood oxygenation (including OXYPLUS, OXYPHAN, and X30 capillary membranes for cardiac surgery and respiratory therapies), hemodialysis and blood purification (including DIAPES, PUREMA, and SYNPHAN capillary membranes), and therapeutic apheresis (including SYNCLEAR, MicroPES, PLASMAPHAN, and FractioPES capillary membranes). These membranes serve as critical components in extracorporeal blood processing devices, enabling separation of blood components while maintaining biocompatibility and clinical efficacy. The company also offers customer-specific membrane manufacturing capabilities alongside standard product lines.

Differentiator

Problem solved

Functional benefit

Brands

• 3M™ Membrana™: Medical membrane materials brand for blood oxygenation, hemodialysis, and therapeutic apheresis applications. Products include OXYPLUS, OXYPHAN, PUREMA, DIAPES, SYNPHAN, MicroPES, PLASMAPHAN, SYNCLEAR, and FractioPES capillary membranes.
• Clarity™
• Solventum™ Fluency™
• Solventum™ Cloud Platform
• Solventum™ 360 Encompass™ System
• Littmann®

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

One partnership is on record.

• Thermo Fisher ScientificflagshipStrategic or Co-development Partner · 1 January 2025Thermo Fisher Scientific completed the acquisition of Solventum's Purification and Filtration Business in 2025. This includes the medical membrane materials business previously part of 3M's Health Care segment. The acquisition integrates Solventum's membrane technology portfolio for biopharmaceutical purification, manufacturing, and OEM applications into Thermo Fisher Scientific's offerings.

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Fresenius Medical Care: Fresenius Medical Care is the world's largest dialysis products and services company, producing dialyzers, dialysis machines, and related consumables. Relevant peer as a vertically integrated buyer and producer of dialysis membranes and a potential OEM customer.
• Nipro Corporation: Nipro manufactures dialyzers and other medical devices, including dialysis membranes. Comparable as a producer of hollow-fiber dialysis membranes and a competitor/supplier in the OEM capillary membrane market.
• Terumo Corporation: Terumo manufactures blood component collection and therapeutic apheresis devices, and is a major participant in the extracorporeal blood processing market. Comparable as an OEM device customer/competitor in apheresis and oxygenation devices.
• Baxter International: Baxter manufactures dialysis machines and related renal care products, and historically has been a major OEM-level participant in extracorporeal blood purification. Comparable as a buyer/integrator of membrane technology in dialysis and apheresis.
• Medtronic: Medtronic offers cardiac surgery and perfusion products and is a broad incumbent in medical devices serving similar procedural end markets (cardiac surgery, oxygenation). Comparable as a downstream device manufacturer that sources capillary membranes.
• B. Braun Avitum: B. Braun's Avitum division produces dialyzers and dialysis equipment, sourcing or producing its own hollow-fiber membranes. Relevant comparable as another vertically integrated dialysis player serving similar clinical end markets.

Direct peers

• Toray Industries (Medical Division): Toray produces hollow-fiber membranes for hemodialysis, hemodiafiltration, and other extracorporeal blood purification applications. Directly competes with 3M Membrana in supplying medical-grade capillary membranes to device OEMs.
• Asahi Kasei Medical: Asahi Kasei Medical is a leading global manufacturer of hollow-fiber membranes for artificial kidneys (dialyzers), therapeutic apheresis, and related blood-purification devices. Directly comparable to 3M Membrana as a supplier of specialty capillary membranes to medical device OEMs in dialysis and apheresis.

Emerging players

• Cytiva (Danaher): Cytiva, now part of Danaher, supplies filtration and purification consumables for biopharmaceutical manufacturing. Comparable as an adjacent membrane/filtration specialist and as a sibling unit under the same acquirer (Thermo Fisher operates in adjacent bioprocessing spaces).
• Sartorius AG: Sartorius supplies filtration and membrane-based products for bioprocessing, an adjacent application of hollow-fiber technology. Comparable as a membrane science specialist expanding into adjacent medical/bioprocessing use cases.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/membrana

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3M